Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RadiaNCe Lung X: Radiation Prior to TKI in Advanced NSCLC
NCT06305715Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Sep 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by Medical College of Wisconsin. Primary endpoint: Progression Free Survival at 18 months. Started Sep 2024; status: recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06305715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305715.